Skip to content

IC-8 Apthera IOL +29.5 DRecalls & reported problems

Bausch & Lomb Incorporated · One-piece UV blocking, hydrophobic acrylic small aperture intraocular lens. · Class 3 · Implant

All models of IC-8 Apthera IOL (20)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00813359021127), received between May 9, 2024 and Oct 17, 2024 — classified as 2 injuries.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break1
  • Device Dislodged or Dislocated1
  • Material Split, Cut or Torn1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1
  • Visual Impairment1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 17, 2024Break; Device Dislodged or Dislocated; Break; Device Dislodged or Dislocated

    IT WAS REPORTED THAT EIGHT DAYS POST IMPLANT OF AN INTRAOCULAR LENS (IOL) INTO THE RIGHT EYE (OD), THE PATIENT COMPLAINED OF NOTICING A DECREASE IN VISION. DURING EXAMINATION, THE SURGEON FOUND THE HAPTIC WAS BROKEN AND THE LENS HAD DISLOCATED. A SUCCESSFUL LENS EXCHANGE USING THE SAME MODEL AND DIOPTER WAS COMPLETED APPROXIMATELY FOUR WEEKS AFTER INITIAL IMPLANT. THE PATIENT'S OUTCOME IS GOOD.

    Patient problems: Visual Impairment

    MAUDE report 20470810 ↗
  • InjuryMay 9, 2024Material Split, Cut or Torn; Material Split, Cut or Torn

    IT WAS REPORTED THAT DURING IMPLANTATION OF AN INTRAOCULAR LENS (IOL), THE IOL CAME OUT OF THE INJECTOR WITH A TEAR IN THE OPTIC., ALLEGEDLY DAMAGED DURING LOADING OR INSERTION. THE IOL WAS REPLACED INTRAOPERATIVELY, AND A SUTURE WAS USED TO CLOSE THE WOUND. THE PATIENT HAS RECOVERED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19278179 ↗

Other Extended Depth Of Focus Intraocular Lens devices

All Extended Depth Of Focus Intraocular Lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page